Welcome to our dedicated page for Regency Ctrs SEC filings (Ticker: REG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Regency Centers Corporation (REG) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a shopping center-focused retail REIT and S&P 500 Index member. Regency Centers files reports for both the corporation and its operating partnership, Regency Centers, L.P., reflecting its structure as a REIT that owns, operates, and develops shopping centers in suburban trade areas.
Among the most informative documents for REG are its periodic reports and current reports on Form 8-K. These filings include earnings releases that discuss net income attributable to common shareholders, Nareit funds from operations (FFO), core operating earnings, same property net operating income (NOI) growth, leasing activity, and occupancy levels. They also provide updates on guidance for full-year performance metrics and details on development and redevelopment spending, acquisitions, and dispositions of shopping centers.
Regency Centers’ 8-K filings further cover capital structure and financing events, such as the issuance of senior unsecured notes, use of its revolving credit facility, and unregistered sales of equity securities through operating partnership units. Filings also document declarations of dividends on common stock and on the company’s 6.250% Series A and 5.875% Series B Cumulative Redeemable Preferred Stock, including payment rates and record dates.
Corporate governance matters appear in filings as well, including the election of directors to the board and committee assignments. Regulation FD disclosures and investor presentation updates are also furnished via Form 8-K, pointing investors to additional materials hosted by the company.
On Stock Titan, AI-powered tools summarize and highlight key points from Regency Centers’ SEC filings, helping readers interpret complex sections related to FFO, NOI, capital allocation, and securities issuance. Real-time updates from EDGAR, combined with AI summaries, make it easier to track new 10-K and 10-Q reports when they are filed, as well as insider and capital markets-related disclosures, without having to parse every line of the original documents.
Regency Centers Corp director Karin Klein reported a stock-based compensation grant. On February 4, 2026, she acquired 428 shares of Regency Centers common stock, reported at a price of $0.00 per share, as director fees paid in stock under Regency's Omnibus Incentive Plan.
Following this grant, Klein beneficially owns 23,198 shares of Regency Centers common stock in direct ownership form. The filing reflects a routine equity compensation award rather than an open-market purchase or sale.
Regency Centers Corporation executive Nicholas Andrew Wibbenmeyer, West Regional President & CIO, reported an equity grant on a Form 4. He received 4,414 shares of restricted stock on February 3, 2026 at a stated price of $0 per share.
The filing shows he now beneficially owns 4,414 derivative securities, held directly. According to the footnote, these restricted shares vest 25% per year beginning February 3, 2027, meaning the award becomes earned gradually over four years.
Regency Centers Corp. executive Alan Todd Roth, Eastern Regional President and Chief Operating Officer, reported an equity award in the form of a restricted stock grant. On February 3, 2026, he received 4,414 restricted shares of common stock at a price of $0 per share, held directly.
The award is subject to a time-based vesting schedule. According to the footnote, the shares vest 25% per year beginning February 3, 2027, meaning the grant becomes fully vested over four years if the conditions are met.
Regency Centers Corp executive vice president and chief financial officer Michael J. Mas reported receiving a restricted stock grant of 5,601 derivative securities on February 3, 2026. These shares vest 25% annually beginning on February 3, 2027. Following this grant, he beneficially owns 5,601 shares directly.
Regency Centers Corp disclosed that Executive Chairman and director Martin E. Stein Jr. received a grant of 2,069 shares of restricted stock on February 3, 2026. The award was granted at a price of $0 per share and is held directly.
The restricted shares are scheduled to vest in four equal installments of 25% per year, beginning on February 3, 2027. Following this grant, Stein beneficially owns 2,069 derivative securities linked to Regency Centers common stock.
Regency Centers Corp. reported a new equity award to its President and CEO, Lisa Palmer. On February 3, 2026, she received a restricted stock grant covering derivative securities tied to 17,934 shares of common stock at a price of $0 per share.
The filing notes these shares vest in stages, with 25% of the award vesting each year beginning on February 3, 2027. The grant is held directly by Palmer and represents stock-based compensation that increases her beneficial ownership as the shares vest over time.
Regency Centers Corporation has elected Mark J. Parrell to its Board of Directors, effective January 1, 2026. In connection with his appointment, the Board size will increase from eleven to twelve members. Parrell currently serves as President, Chief Executive Officer and a member of the Board of Trustees of Equity Residential (NYSE: EQR).
His term will run until the company’s 2026 annual meeting of stockholders, and he will initially serve on the Audit and Investment committees. Regency Centers determined that he is independent under Nasdaq Stock Market listing standards. As a non-employee director, he will participate in the standard program, including a $75,000 annual cash retainer, additional committee retainers, and an annual common stock rights grant valued at $125,000, prorated for his service until the 2026 annual meeting.
Regency Centers Corp (REG) insider reported an open-market sale. The Reporting Person, who is a Director and Executive Chairman, sold 15,000 shares of common stock at a weighted average price of $70.02 on 11/10/2025, with individual trades executed between $70.00 and $70.10.
After the transaction, the Reporting Person beneficially owned 272,958 shares directly. Indirect holdings were listed as 24,201 shares by a trust, 110,263 shares by a corporation, 325,382 shares by two general partnerships, and 4,000 shares by a trust for the Reporting Person’s benefit.
Regency Centers (REG) reported an insider transaction on a Form 4. On 11/06/2025, a Director acquired 473 shares of common stock, recorded as an “A” code transaction and noted as director fees paid in stock under Regency’s Omnibus Incentive Plan.
Following this grant, the reporting person beneficially owns 111,870 shares, held directly. No derivative securities were reported in this filing.
Regency Centers (REG) reported an insider transaction by a director. On 11/06/2025, the director acquired 351 shares of common stock, recorded as an “A” code. The filing notes this represents director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Following the transaction, the director beneficially owns 53,243 shares, held directly. This is a routine equity compensation entry disclosed on Form 4.